Correlation of glatiramer acetate (GA) antibodies and cytokine shifts with clinical response to GA on multiple sclerosis

被引:0
|
作者
Valenzuela, Reuben M.
Sicsic, Camille
Brenner, Talma
Dhib-Jalbut, Suhayl
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [21] Glatiramer acetate for the treatment of multiple sclerosis
    Wolinsky, JS
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 875 - 891
  • [22] Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+T-cell repertoire in multiple sclerosis
    Biegler, Brian W.
    Yan, Shirley X.
    Ortega, Sterling B.
    Tennakoon, Deepani K.
    Racke, Michael K.
    Karandikar, Nitin J.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 180 (1-2) : 159 - 171
  • [23] Oligoclonal CD8+ T-cell responses to glatiramer acetate (GA; Copaxone®) in patients with multiple sclerosis
    Yan, X
    Ortega, S
    Mehta, R
    Douek, DC
    Koup, R
    Racke, MK
    Karandikar, NJ
    FASEB JOURNAL, 2003, 17 (07): : C275 - C275
  • [24] Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis
    Wiesemann, E
    Klatt, J
    Wenzel, C
    Heidenreich, F
    Windhagen, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (03): : 454 - 460
  • [25] Treatment with glatiramer acetate (GA) induces and restores CD8+T-cell responses in patients with multiple sclerosis
    Karandikar, NJ
    Crawford, MP
    Ratts, RB
    Brenchley, JM
    Ambrozak, DR
    Lovett-Racke, AE
    Douek, DC
    Koup, RA
    Racke, MK
    NEUROLOGY, 2002, 58 (07) : A246 - A246
  • [26] HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis
    Dhib-Jalbuta, Suhayl
    Valenzuela, Reuben M.
    Ito, Kouichi
    Kaufman, Michael
    Picone, Mary Ann
    Buyske, Steve
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (04) : 340 - 348
  • [27] Clinical significance of glatiramer acetate antibodies
    Blanchette, F.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S28 - S35
  • [28] Antibodies to glatiramer acetate in long-term treated multiple sclerosis patients
    Teitelbaum, D
    Arnon, R
    Karussis, D
    Abramsky, O
    Brenner, T
    MULTIPLE SCLEROSIS, 2005, 11 : S163 - S163
  • [29] JNK As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis
    Anselmo, Freidrich
    Tatomir, Alexandru
    Ciriello, Jonathan
    Rus, Horea
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 26 - 26
  • [30] The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis
    Sormani, MP
    Bruzzi, P
    Comi, G
    Filippi, M
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (04) : 447 - 449